Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Localized Chemotherapy to the Liver Spares Healthy Tissue

18.08.2004


In this retrospective study, eighty-eight patients with advanced hepatocellular carcinoma (HCC) were treated with long-term chemotherapy infusion into the hepatic artery, the main artery that supplies the liver. Known as hepatic arterial chemotherapy, this treatment requires a reservoir/pump system to supply the drug directly to the liver and the liver cancer. The reservoir port systems currently available have to be surgically implanted, making this treatment unavailable to many patients who were unable or unwilling to have the implant. Interventional radiologists -- vascular experts who are uniquely skilled in using the vascular system to deliver targeted treatments via catheter throughout the body -- adapted conventional venous ports to use in the arterial circulation. In this method, the interventional radiologist implanted the reservoir and then embolized – mechanically blocked – the arteries to the adjacent areas during the port placement to prevent the influx of drugs to areas outside of the liver. This is beneficial because the chemotherapy drug is only circulated to the organ with the cancer, so the drug does not harm healthy tissue throughout the body. This allows for a higher dose of chemotherapy drug to be used, because the drug is contained.

Hepatic Arterial Infusion Chemotherapy

The hepatic arterial infusion chemotherapy was initiated after reservoir implantation on an outpatient basis. The infusion protocols were decided for each patient by the physician in charge and chemotherapeutic agents were administered every 1–4 weeks. In 55 patients, cisplatin (10 mg/m2) and 5-fluorouracil (1,000 mg/m2) were given at 1 hour and 5 hours, respectively. In the other 33 patients, doxorubicin hydrochloride or epirubicin hydrochloride (10–20 mg/m2) were injected every 2–4 weeks in a "one-shot" manner.



Implantation of Reservoir and Response to Arterial Infusion Chemotherapy
Reservoirs were successfully implanted in all patients. Arterial infusion chemotherapy was performed 13.1 times per patient on average. Tumors completely disappeared in one patient (complete response, 1%), shrunk at least 50% in maximum diameter in 14 patients (partial response, 16%), shrunk 25%–50% in five patients (minor response, 6%), and remained stable in 68 patients (77%). No tumors showed progression. The tumor response rate (complete and partial responses) was 17%.

Survival

The follow-up period ranged from 1.4 months to 41.4 months, with a mean of 12.0 months. The estimated 1-, 2-, and 3-year survival rates were 55%, 36%, and 24% in all patients, with a mean survival period of 19.5 months ± 1.9.

This study showed similar results as those achieved in previous studies. The therapeutic response rate, 1-year survival rate, and mean survival time were 17%, 55%, and 19.5 months, respectively. By comparison, Okuda et al, analyzed the natural history of HCC and reported the prognoses of untreated patients. The median survival times were 0.7 months in patients with Okuda stage III disease, 2.0 months in those with stage II disease, and 8.3 months in those with stage I disease. The survival of patients with portal venous invasion has been reported to be 3–4 months. Arterial infusion chemotherapy seems to improve survival in patients with HCC. In the present study, the mean survival periods were more than 1 year even in patients with Okuda stage II/III disease (15 months) and in those with portal venous invasion (16 months).

Prognostic Factors Identified

In the univariable analysis, the following eight variables were significantly linked with better prognosis: (i) tumor extension less than 50% of liver volume, (ii) CLIP score 0–2, (iii) Okuda stage I, (iv) alkaline phosphatase level of less than 140 IU/L, (v) absence of ascites, (vi) aspartate aminotransferase level less than 80 IU/L, (vii) good therapeutic response, and (viii) lack of portal venous invasion. When multiple variables were analyzed, the CLIP score, Okuda stage, and therapeutic effect were found to be significant prognostic factors with independent value for survival.

Although these results should be confirmed in future prospective studies, these prognostic factors should prove helpful in determining which patients with advanced HCC may benefit from arterial infusion chemotherapy with an implanted port system.

| newswise
Further information:
http://www.sirweb.org
http://www.jvir.org

More articles from Health and Medicine:

nachricht New study points the way to therapy for rare cancer that targets the young
22.11.2017 | Rockefeller University

nachricht Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Corporate coworking as a driver of innovation

22.11.2017 | Business and Finance

PPPL scientists deliver new high-resolution diagnostic to national laser facility

22.11.2017 | Physics and Astronomy

Quantum optics allows us to abandon expensive lasers in spectroscopy

22.11.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>